Managing antituberculosis drug therapy by therapeutic drug monitoring of rifampicin and isoniazid
- 19 May 2003
- journal article
- research article
- Published by Wiley in Internal Medicine Journal
- Vol. 33 (5-6) , 229-234
- https://doi.org/10.1046/j.1445-5994.2003.00390.x
Abstract
Background: Current therapeutic regimens with rifampicin and isoniazid have proven successful in treating tuberculosis, however, toxicity, therapeutic failure, relapse and multiple drug resistance a...Keywords
This publication has 29 references indexed in Scilit:
- Comparative Pharmacokinetics and Pharmacodynamics of the Rifamycin AntibacterialsClinical Pharmacokinetics, 2001
- Delayed Death From Pulmonary TuberculosisSouthern Medical Journal, 2000
- Isoniazid Toxicity in Health Care WorkersClinical Infectious Diseases, 1999
- Therapeutic Drug Monitoring in Antituberculosis ChemotherapyTherapeutic Drug Monitoring, 1998
- Rifampin StabilityTherapeutic Drug Monitoring, 1998
- Stability of Rifampin in PlasmaTherapeutic Drug Monitoring, 1997
- Pharmacokinetics of Antituberculosis Drugs in PatientsThe Journal of Clinical Pharmacology, 1987
- High-Pressure Liquid Chromatographic Quantitation of Rifampin and Its Two Major Metabolites in Urine and SerumClinical Infectious Diseases, 1983
- Clinical Pharmacokinetics of IsoniazidClinical Pharmacokinetics, 1979
- Clinical Pharmacokinetics of RifampicinClinical Pharmacokinetics, 1978